Introduction: Kidneys are the critical organs in PRRT. A dosimetry protocol was implemented in an ongoing study to estimate the biological effective dose (BED) on the kidneys after 90Y-DOTATOC therapy.
Aim(s): 111In-octreotide dosimetry with amino acid infusion is feasible and can be used in the prediction of post-PRRT evolution of the renal function.
Materials and methods: Whole body images were acquired at four time points after an 111In-octreotide injection with 2L amino acid coinfusion, assuming similar kinetics of 111In-octreotide and 90Y-DOTATOC. Regions of interest were drawn, blood and urine were collected, kidney volumes were measured, and all put into OLINDA software, which led to organ BED after four cycles 90Y-DOTATOC.
Conference: 8th Annual ENETS Conference (2011)
Presenting Author: Dr. Sofie M.D.A. Van Binnebeek
To read results and conclusion, please login ...
Further abstracts you may be interested in